Evidence map›Paper›PMID 29953169›Full record

ArticleAlcoholism, clinical and experimental research2018

S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood-Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use Disorder.

Jennifer M Loftis, Juno Valerio, Jonathan Taylor, Elaine Huang, Rebekah Hudson, Patricia Taylor-Young, Michael Chang, Samuel B Ho, Eric Dieperink, Juan Luis Miranda and 1 more

Abstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Jennifer M LoftisResearch & Development Service , VA Portland Health Care System, Portland, Oregon.ORCID http://orcid.org/0000-0003-1773-9365
Juno ValerioResearch & Development Service , VA Portland Health Care System, Portland, Oregon.
Jonathan TaylorResearch & Development Service , VA Portland Health Care System, Portland, Oregon.
Elaine HuangResearch & Development Service , VA Portland Health Care System, Portland, Oregon.
Rebekah HudsonResearch & Development Service , VA Portland Health Care System, Portland, Oregon.
Patricia Taylor-YoungNursing Research Department , VA Portland Health Care System, Portland, Oregon.
Michael ChangGastroenterology , VA Portland Health Care System, Portland, Oregon.
Samuel B HoVA San Diego Healthcare System , San Diego, California.
Eric DieperinkMinneapolis VA Healthcare System , Minneapolis, Minnesota.
Juan Luis MirandaVA Long Beach Health Care System , Long Beach, California.
Peter HauserVA Long Beach Health Care System , Long Beach, California.
Oregon Health & Science University · USUniversity of San Diego · USVA Portland Health Care System · USUniversity of Minnesota · USVA Long Beach Healthcare System · US

Funding

Traditional Service Core [Translational Service Core (TSC)]P50DA018165 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI HOFFMAN, WILLIAM FRANKLIN · 2006 to 2016
$13.0M
HCV and co-morbid alcohol use disorders: a translational investigation of antiviral therapy outcomes on CNS functionI01BX002061 · VA · PORTLAND VA MEDICAL CENTER · PI LOFTIS, JENNIFER M · 2014 to 2023
–
Efficacy & safety of baclofen to reduce alcohol use in veterans with HCVI01CX000277 · VA · VETERANS HEALTH ADMINISTRATION · PI HAUSER, PETER · 2009 to 2013
–
BLRD VA I01 BX002061CSRD VA I01 CX000277NIDA NIH HHS P50 DA018165
6 · The paper itself

Abstract

backgroundHepatitis C virus (HCV) infection and alcohol use disorder (AUD) both adversely affect the immune system resulting in alterations in immune cell signaling and inflammatory processes. The aim of this study was to investigate how comorbid AUD contributes to abnormalities in inflammatory mediators and psychiatric impairments in adults with HCV.

methodsAlcohol use, mood, and inflammatory factors were evaluated at 3 time points (baseline, week 4, and week 12) in Veterans with HCV, with (n = 42) and without (n = 13) comorbid AUD. Peripheral indices of immune activation, blood-brain barrier (BBB) damage (S100 calcium-binding protein B [S100B]), liver function, and viral load were measured using immunoassays and polymerase chain reaction assays.

resultsComorbid AUD was associated with increased symptoms of depression and anxiety, elevated levels of liver enzymes, and altered expression of inflammatory factors. Alcohol consumption was positively correlated with the severity of psychiatric symptoms. Univariate analysis identified significant group differences in interleukin (IL)-8 (p = 0.006), IL-10 (p = 0.03), and S100B (p = 0.048), with increased levels in participants with AUD, which persisted over time despite reductions in alcohol use and no significant change in HCV viral load. Statistically significant effects of study group or time were not found for the other immune factors assessed. Exploratory receiver operating characteristic curve analysis evaluated the ability of IL-8, IL-10, and S100B to differentiate between levels of alcohol consumption and generated biomarker cutoff values used to identify low risk and unhealthy alcohol use groups.

conclusionsThese results demonstrate that HCV and comorbid AUD are associated with greater psychiatric impairments, potentially resulting from increased inflammation, dysregulated cytokine expression, and compromised BBB function. Alcohol-induced BBB damage may increase the risk of neuropathological consequences within the context of chronic HCV infection.

Indexed as

Alcohol Use DisordersBlood-Brain BarrierCytokinesDepressionHepatitis C

Identifiers

PMID29953169
PMCPMC6310679
OpenAlexW2810111649

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.